| Title | Nonpharmacologic treatment of atrial fibrillation: current and evolving strategies. | | Author(s) | Iskos D, Fahy GJ, Lurie KG, Sakaguchi S, Adkisson WO, Benditt DG | | Institution | Cardiac Arrhythmia Center, Department of Medicine, University of Minnesota Medical School, Minneapolis, USA. | | Source | Chest 1997 Oct; 112(4):1079-90. | | MeSH | Anti-Arrhythmia Agents
Atrial Fibrillation
Atrioventricular Node
Cardiac Pacing, Artificial
Catheter Ablation
Defibrillators, Implantable
Electric Countershock
Forecasting
Heart Rate
Humans
Recurrence
Ventricular Function
| | Abstract | Atrial fibrillation is the most common cardiac arrhythmia requiring treatment. Limitations of medical treatment have prompted development of nonpharmacologic therapies for this arrhythmia. These are aimed at ventricular rate control during atrial fibrillation, termination of the arrhythmia, and/or prevention of recurrences. Ventricular rate control can be achieved with transcatheter ablation or modification of the atrioventricular node. The MAZE operation is effective in preventing arrhythmia recurrence, but because it requires cardiac surgery, its appeal is limited. Development of the technique for direct transcatheter ablation of atrial fibrillation is eagerly anticipated and may represent the standard curative treatment of the future. In appropriately selected patients, implantable device therapy may play an important role in the treatment of paroxysmal atrial fibrillation. | | Language | eng | | Pub Type(s) | Journal Article
Review
| | PubMed ID | 9377921 |
|
